Fields
Biology / MedicalSectors
Health
TAX2 is a new peptide-based drug with anti-angiogenic properties, designed through innovative interdisciplinary approaches (bioinformatics, molecular modeling, biochemical and molecular biology).
The peptide has specific antagonistic properties of the interaction thrombospondin-1 (TSP-1):CD47, which has many pharmacological and therapeutic consequences.
Benefits: